To evaluate Jiangxia umbilical therapy on the quality of life in patients with gastric carcinoma chemotherapy after surgery.

Patients with gastric carcinoma chemotherapy after surgery in the Third Affiliated Hospital of Sun Yat-Sen University from January 2016 to December 2016 were chosen as the research subjects.According to the time of chemotherapy, the patients were divided into two groups.Patients with gastric carcinoma chemotherapy in hospital from January 2016 to June 2016 were chosen as control group, while patients in hospital from July 2016 to December 2016 were chosen as observation group.Before chemotherapy, the control group was given tropisetron hydrochloride intravenous injection, while the observation group added Jiangxia umbilical on the basis of this.Nausea and vomiting in the two groups were observed after treatment.Quality of Life Questionnaire of Stomach 22 was applied to analyze and compare the patients' quality of life.

The incidence rate of anti-nausea in the observation group was 88.10%, which in the control group was 61.90%, the difference was statistically significant (χ²=9.571, P<0.05). The overall quality of life in observation group was significantly better than that in the control group[(20.34±5.84)points vs.(14.32±5.97)points, t=8.686, P<0.01]. The scores in the observation group on the quality of life in the aspects of total score, anxiety scale, reflux scale, eating restricted scale, dry mouth, tastes changing had statistically significant differences compared with the indicators in the control group (all P<0.05).

Jiangxia umbilical therapy can not only relieve the chemotherapy-induced nausea and vomiting of patients with gastric carcinoma chemotherapy after surgery, but also can improve their quality of life.

Stomach neoplasms; Drug therapy; Umbilical compress therapy; Quality of life